June 22, 2018 | Story Review

One blood test to diagnose diabetes? HealthDay doesn’t address harms of overdiagnosis and overtreatment

For help understanding medical tests such as these, see our primer: Understanding medical tests: sensitivity, specificity, and positive predictive value.

3 Star

One Blood Test Might Be Enough to Diagnose Diabetes

June 21, 2018 | Story Review

Newsweek’s story on the 16:8 diet: It’s not much more than a news release rewrite, but it’s at least cautious

The story also would have been stronger had it used people-first language to help reduce stigma around obesity.

3 Star

16:8 FASTING DIET LINKED TO WEIGHT LOSS AND HEALTH BENEFITS IN STUDY

June 14, 2018 | Story Review

Here’s one detail that should be included in almost all stories about cancer screening studies

This is an oversight we see often in news stories reporting on research about new cancer screening tests.

3 Star

NEW PROSTATE CANCER DNA SPIT TEST DEVELOPED BY SCIENTISTS

June 12, 2018 | Story Review

BuzzFeed warns readers ‘a lot more work to be done’ to find out if experimental blood test can predict preterm birth

The story would have benefited from an outside expert weighing on the study and its potential ramifications and — more importantly — the potential harms of a false-positive test, which are not insignificant.

4 Star

This Blood Test Could Help Predict If A Pregnancy Is At Risk For Premature Labor

June 8, 2018 | Story Review

In story on texting program for chemo patients, Reuters Health keeps most study details on the DL

Technology isn’t a panacea and news stories should quantify the purported benefits just as they would for drugs and other interventions.

2 Star

Automatic texting helps ease stress of chemotherapy in breast cancer patients

June 6, 2018 | Story Review

NPR (yet again) writes uncritically about ketamine for mental illness

The story makes sweeping statements, without support, favoring the use of ketamine to treat a vast array of ills.

1 Star

From Chaos To Calm: A Life Changed By Ketamine

June 4, 2018 | Story Review

Numerous problems plague Guardian’s coverage of ‘holy grail of cancer research’

The Guardian story not only misleads readers with a grandiose headline, it fails to provide readers with a balanced discussion of the significant limitations and harms that many experts consider salient when it comes to liquid biopsies.

2 Star

'Holy grail of cancer research': doctors positive about early detection blood test

May 31, 2018 | Story Review

LA Times provides careful take on early brain/diabetes research–except for the headline

The headline undermines the overall message of the story with phrasing suggesting a new treatment option: “may offer treatment”

4 Star

Deep brain stimulation may offer treatment for type 2 diabetes, study suggests

May 29, 2018 | Story Review

HealthDay rehashes a news release claiming researchers have found new type of vertigo

The story should have provided some counter-balance to this viewpoint — is it really a new diagnosis?

1 Star

Newly Identified Form of Vertigo Responds to Treatment

May 22, 2018 | Story Review

A study that may help reduce overtreatment of breast cancer gets solid write-up by Bloomberg

The story also makes clear that this finding is not robust enough to change treatment guidelines yet and that other outcomes, such as quality of life improvement are still being analyzed.

4 Star

Study Finds More Isn't Better for Roche Breast Cancer Drug

Toolkit

Tips & Resources for Analyzing Health Care Claims

View More

Toolkit